rhPTX-2 (PRM-151)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for rhPTX-2 (PRM-151), covering 2024-04-18 to 2024-04-18. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Recombinant Human Pentraxin-2 (rhPTX-2; PRM-151) in Participants With Idiopathic Pulmonary Fibrosis [Phase 3]